A citation-based method for searching scientific literature

Ju-Seog Lee. Clin Mol Hepatol 2015
Times Cited: 61







List of co-cited articles
315 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
Kornelius Schulze, Sandrine Imbeaud, Eric Letouzé, Ludmil B Alexandrov, Julien Calderaro, Sandra Rebouissou, Gabrielle Couchy, Clément Meiller, Jayendra Shinde, Frederic Soysouvanh,[...]. Nat Genet 2015
782
29

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes.
Yasushi Totoki, Kenji Tatsuno, Kyle R Covington, Hiroki Ueda, Chad J Creighton, Mamoru Kato, Shingo Tsuji, Lawrence A Donehower, Betty L Slagle, Hiromi Nakamura,[...]. Nat Genet 2014
414
22

Sorafenib in advanced hepatocellular carcinoma.
Josep M Llovet, Sergio Ricci, Vincenzo Mazzaferro, Philip Hilgard, Edward Gane, Jean-Frédéric Blanc, Andre Cosme de Oliveira, Armando Santoro, Jean-Luc Raoul, Alejandro Forner,[...]. N Engl J Med 2008
21

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Jean Charles Nault, Maxime Mallet, Camilla Pilati, Julien Calderaro, Paulette Bioulac-Sage, Christophe Laurent, Alexis Laurent, Daniel Cherqui, Charles Balabaud, Jessica Zucman-Rossi. Nat Commun 2013
367
19

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, Yannick Ladeiro, Laura Pelletier, Ichrafe Ben Maad, Julien Calderaro, Paulette Bioulac-Sage, Mélanie Letexier, Françoise Degos,[...]. Nat Genet 2012
873
19

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.
Zhengyan Kan, Hancheng Zheng, Xiao Liu, Shuyu Li, Thomas D Barber, Zhuolin Gong, Huan Gao, Ke Hao, Melinda D Willard, Jiangchun Xu,[...]. Genome Res 2013
327
16

Identification of driver genes in hepatocellular carcinoma by exome sequencing.
Sean P Cleary, William R Jeck, Xiaobei Zhao, Kui Chen, Sara R Selitsky, Gleb L Savich, Ting-Xu Tan, Michael C Wu, Gad Getz, Michael S Lawrence,[...]. Hepatology 2013
195
16


Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.
Sung-Min Ahn, Se Jin Jang, Ju Hyun Shim, Deokhoon Kim, Seung-Mo Hong, Chang Ohk Sung, Daehyun Baek, Farhan Haq, Adnan Ahmad Ansari, Sun Young Lee,[...]. Hepatology 2014
219
14

Hepatocellular carcinoma.
Josep M Llovet, Jessica Zucman-Rossi, Eli Pikarsky, Bruno Sangro, Myron Schwartz, Morris Sherman, Gregory Gores. Nat Rev Dis Primers 2016
997
13

Hepatocellular carcinoma.
Alejandro Forner, Josep M Llovet, Jordi Bruix. Lancet 2012
11

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.
Meng Li, Hong Zhao, Xiaosong Zhang, Laura D Wood, Robert A Anders, Michael A Choti, Timothy M Pawlik, Hubert D Daniel, Rajesh Kannangai, G Johan A Offerhaus,[...]. Nat Genet 2011
289
11

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang,[...]. Lancet Oncol 2009
11

Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Jessica Zucman-Rossi, Augusto Villanueva, Jean-Charles Nault, Josep M Llovet. Gastroenterology 2015
553
11

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Jordi Bruix, Shukui Qin, Philippe Merle, Alessandro Granito, Yi-Hsiang Huang, György Bodoky, Marc Pracht, Osamu Yokosuka, Olivier Rosmorduc, Valeriy Breder,[...]. Lancet 2017
11

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators.
Akihiro Fujimoto, Yasushi Totoki, Tetsuo Abe, Keith A Boroevich, Fumie Hosoda, Ha Hai Nguyen, Masayuki Aoki, Naoya Hosono, Michiaki Kubo, Fuyuki Miya,[...]. Nat Genet 2012
592
9

Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Maria Lina Tornesello, Luigi Buonaguro, Fabiana Tatangelo, Gerardo Botti, Francesco Izzo, Franco M Buonaguro. Genomics 2013
85
9

Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015
9

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
9

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.
Hashem B El-Serag, K Lenhard Rudolph. Gastroenterology 2007
8

Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma.
Jian Huang, Qing Deng, Qun Wang, Kun-Yu Li, Ji-Hong Dai, Niu Li, Zhi-Dong Zhu, Bo Zhou, Xiao-Yan Liu, Rui-Fang Liu,[...]. Nat Genet 2012
269
8

Advances in targeted therapies for hepatocellular carcinoma in the genomic era.
Josep M Llovet, Augusto Villanueva, Anja Lachenmayer, Richard S Finn. Nat Rev Clin Oncol 2015
271
8

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial.
Anthony B El-Khoueiry, Bruno Sangro, Thomas Yau, Todd S Crocenzi, Masatoshi Kudo, Chiun Hsu, Tae-You Kim, Su-Pin Choo, Jörg Trojan, Theodore H Welling,[...]. Lancet 2017
8

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
8

Hepatocellular Carcinoma.
Augusto Villanueva. N Engl J Med 2019
915
8

Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
H Nakabayashi, K Taketa, K Miyano, T Yamane, J Sato. Cancer Res 1982
6

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
6

Exploration of liver cancer genomes.
Tatsuhiro Shibata, Hiroyuki Aburatani. Nat Rev Gastroenterol Hepatol 2014
117
6

Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Fukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, Sei Kakinuma, Miyako Murakawa, Sayuri Nitta, Takako Watanabe, Satoshi Otani, Miki Taniguchi, Fumio Goto,[...]. J Gastroenterol 2016
56
7

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
Wing-Kin Sung, Hancheng Zheng, Shuyu Li, Ronghua Chen, Xiao Liu, Yingrui Li, Nikki P Lee, Wah H Lee, Pramila N Ariyaratne, Chandana Tennakoon,[...]. Nat Genet 2012
546
6

Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.
Andrew X Zhu, Masatoshi Kudo, Eric Assenat, Stéphane Cattan, Yoon-Koo Kang, Ho Yeong Lim, Ronnie T P Poon, Jean-Frederic Blanc, Arndt Vogel, Chao-Long Chen,[...]. JAMA 2014
384
6

Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
Hyun Goo Woo, Xin Wei Wang, Anuradha Budhu, Yun Hee Kim, So Mee Kwon, Zhao-You Tang, Zongtang Sun, Curtis C Harris, Snorri S Thorgeirsson. Gastroenterology 2011
87
6

Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study.
Philip J Johnson, Shukui Qin, Joong-Won Park, Ronnie T P Poon, Jean-Luc Raoul, Philip A Philip, Chih-Hung Hsu, Tsung-Hui Hu, Jeong Heo, Jianming Xu,[...]. J Clin Oncol 2013
490
6

Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial.
Ann-Lii Cheng, Yoon-Koo Kang, Deng-Yn Lin, Joong-Won Park, Masatoshi Kudo, Shukui Qin, Hyun-Cheol Chung, Xiangqun Song, Jianming Xu, Guido Poggi,[...]. J Clin Oncol 2013
481
6

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Diego F Calvisi, Sara Ladu, Alexis Gorden, Miriam Farina, Elizabeth A Conner, Ju-Seog Lee, Valentina M Factor, Snorri S Thorgeirsson. Gastroenterology 2006
501
6

Emerging trends in hepatocellular carcinoma incidence and mortality.
Basile Njei, Yaron Rotman, Ivo Ditah, Joseph K Lim. Hepatology 2015
319
6

Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
Giovanna Fattovich, Tommaso Stroffolini, Irene Zagni, Francesco Donato. Gastroenterology 2004
6

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
6

Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.
Eric T Sawey, Maia Chanrion, Chunlin Cai, Guanming Wu, Jianping Zhang, Lars Zender, Alice Zhao, Ronald W Busuttil, Herman Yee, Lincoln Stein,[...]. Cancer Cell 2011
288
6

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Derek Y Chiang, Augusto Villanueva, Yujin Hoshida, Judit Peix, Philippa Newell, Beatriz Minguez, Amanda C LeBlanc, Diana J Donovan, Swan N Thung, Manel Solé,[...]. Cancer Res 2008
404
6

MDM2-p53 pathway in hepatocellular carcinoma.
Xuan Meng, Derek A Franklin, Jiahong Dong, Yanping Zhang. Cancer Res 2014
125
6

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.
Ju-Seog Lee, Jeonghoon Heo, Louis Libbrecht, In-Sun Chu, Pal Kaposi-Novak, Diego F Calvisi, Arsen Mikaelyan, Lewis R Roberts, Anthony J Demetris, Zongtang Sun,[...]. Nat Med 2006
685
6


Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.
James J Harding, Subhiksha Nandakumar, Joshua Armenia, Danny N Khalil, Melanie Albano, Michele Ly, Jinru Shia, Jaclyn F Hechtman, Ritika Kundra, Imane El Dika,[...]. Clin Cancer Res 2019
146
6


Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.
Asmaa-Ibrahim Gomaa, Shahid-A Khan, Mireille-B Toledano, Imam Waked, Simon-D Taylor-Robinson. World J Gastroenterol 2008
439
4

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.
Jordi Bruix, Jean-Luc Raoul, Morris Sherman, Vincenzo Mazzaferro, Luigi Bolondi, Antonio Craxi, Peter R Galle, Armando Santoro, Michel Beaugrand, Angelo Sangiovanni,[...]. J Hepatol 2012
515
4

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.
Willscott E Naugler, Toshiharu Sakurai, Sunhwa Kim, Shin Maeda, Kyounghyun Kim, Ahmed M Elsharkawy, Michael Karin. Science 2007
4

Hepatocellular carcinoma pathogenesis: from genes to environment.
Paraskevi A Farazi, Ronald A DePinho. Nat Rev Cancer 2006
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.